Your browser doesn't support javascript.
loading
A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.
Jatoi, A; Steen, P D; Atherton, P J; Moore, D F; Rowland, K M; Le-Lindqwister, N A; Adonizio, C S; Jaslowski, A J; Sloan, J; Loprinzi, C.
Afiliación
  • Jatoi A; Division of Medical Oncology, Mayo Clinic, Rochester.
  • Steen PD; Sanford Health NCORP, Fargo.
  • Atherton PJ; Division of Medical Oncology, Mayo Clinic, Rochester.
  • Moore DF; Wichita Community Clinical Oncology Program, Wichita.
  • Rowland KM; Carle Cancer Center CCOP, Urbana.
  • Le-Lindqwister NA; Illinois Oncology Research Assn. CCOP, Peoria.
  • Adonizio CS; Geisinger Clinic & Medical Center CCOP, Danville.
  • Jaslowski AJ; St. Vincent Regional Cancer Center CCOP, Green Bay, USA.
  • Sloan J; Division of Medical Oncology, Mayo Clinic, Rochester.
  • Loprinzi C; Division of Medical Oncology, Mayo Clinic, Rochester.
Ann Oncol ; 28(8): 1957-1963, 2017 Aug 01.
Article en En | MEDLINE | ID: mdl-28475678
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pérdida de Peso / Anorexia / Creatina / Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pérdida de Peso / Anorexia / Creatina / Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article